NCT02148809

Brief Summary

Hypotensive Anesthesia is a type of regional anesthesia performed routinely at our hospital. This type of anesthesia reduces the average arterial pressure. Benefits include reduced bleeding and lower risk of blood clots. The purpose of this study is to determine the effect of intravenous fluids administered with hypotensive anesthesia on your blood volume. With this parameter we will be able to understand how much of your blood is lost because of bleeding and how much of the drop is related to dilution. Study hypothesis: Hemodilution associated with intravenous fluid substitution during hypotensive anesthesia results in decreased postoperative hemoglobin (Hb) levels

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 28, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
12 months until next milestone

Results Posted

Study results publicly available

June 14, 2017

Completed
Last Updated

June 14, 2017

Status Verified

May 1, 2017

Enrollment Period

1.5 years

First QC Date

May 23, 2014

Results QC Date

April 3, 2017

Last Update Submit

May 17, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Total Blood Volume

    The primary outcome is the change in total blood volume (TBV) during the first 6 hours after primary THA utilizing hypotensive anesthesia. Preoperative TBV will be compared to values 6 hours postoperatively.

    preoperatively and 6 hours postoperatively

Other Outcomes (1)

  • Change IN Plasma Volume PV

    preoperative and 6 hours postoperatively

Study Arms (1)

Blood Volume Analysis, Fluid

EXPERIMENTAL

Preop I-131 is given and the BVA is performed, 6 hours after surgery the same procedure will be done to compare the TBV at both points

Radiation: 1mL of I-131 Human Serum Albumin is injected prior to the measurements

Interventions

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non- inflammatory degenerative joint disease of the hip
  • Patients scheduled for unilateral primary total hip arthroplasty
  • Age between 50 and 75 years
  • Hypotensive Spinal-epidural anesthesia with systolic BP \< 95 and diastolic BP \< 65.
  • Adequate intraoperative fluid loading: a minimum of 3 L within 6 hours of surgery

You may not qualify if:

  • Pregnant women or nursing mothers.
  • Women of childbearing potential not using adequate birth control methods
  • Known hypersensitivity to I-131 albumin or any other component of the Volumex injection kit
  • Blood coagulopathies resulting in a hypocoagulable state (hemophilia, von Willebrand disease, etc.)
  • Blood coagulopathies resulting in a hypercoagulable state (factor V leiden, antithrombin III deficiency, protein C deficiency, protein S deficiency)
  • Patients on anti-coagulants (coumadin, plavix, pradaxa, heparin)
  • Congestive Heart Failure (at least one medication to treat congestive heart failure)
  • Coronary artery disease (s/p bypass, stent or AMI)
  • Kidney insufficiency (creatinine \> 1.5)
  • Aortic or mitral valve disease
  • Pulmonary hypertension
  • Revision Hip Surgery
  • Inadequate intravenous fluid substitution within the first 6 hrs (\<3 liters)
  • Inadequate hypotensive anesthesia (mean arterial pressure above 65 for more than 33% of the surgical time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Related Publications (5)

  • Niemi TT, Pitkanen M, Syrjala M, Rosenberg PH. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand. 2000 Apr;44(4):457-64. doi: 10.1034/j.1399-6576.2000.440418.x.

    PMID: 10757582BACKGROUND
  • Hahn RG. Haemoglobin dilution from epidural-induced hypotension with and without fluid loading. Acta Anaesthesiol Scand. 1992 Apr;36(3):241-4. doi: 10.1111/j.1399-6576.1992.tb03457.x.

    PMID: 1574972BACKGROUND
  • Holte K, Foss NB, Svensen C, Lund C, Madsen JL, Kehlet H. Epidural anesthesia, hypotension, and changes in intravascular volume. Anesthesiology. 2004 Feb;100(2):281-6. doi: 10.1097/00000542-200402000-00016.

    PMID: 14739801BACKGROUND
  • Drobin D, Hahn RG. Time course of increased haemodilution in hypotension induced by extradural anaesthesia. Br J Anaesth. 1996 Aug;77(2):223-6. doi: 10.1093/bja/77.2.223.

    PMID: 8881630BACKGROUND
  • Manzone TA, Dam HQ, Soltis D, Sagar VV. Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study. J Nucl Med Technol. 2007 Jun;35(2):55-63; quiz 77, 79. doi: 10.2967/jnmt.106.035972. Epub 2007 May 11.

    PMID: 17496003BACKGROUND

Results Point of Contact

Title
Dr. Friedrich Boettner
Organization
HospitalSS

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2014

First Posted

May 28, 2014

Study Start

May 1, 2014

Primary Completion

November 1, 2015

Study Completion

July 1, 2016

Last Updated

June 14, 2017

Results First Posted

June 14, 2017

Record last verified: 2017-05

Locations